Protara Therapeutics outlines 2026 milestones for cancer trials

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/12/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. SPCX
9. TLT
10. PMTS

Go back to Protara Therapeutics outlines 2026 milestones for cancer trials
(NASDAQ: TARA) Delayed: 3.82 +0.03 (0.79%)
Previous Close $3.79    52 Week High $ 
Open $3.83    52 Week Low $ 
Day High $3.95    P/E N/A 
Day Low $3.81    EPS $ 
Volume 532,027